US12201638B2 - Pharmaceutical Compositions Comprising (2s)-N-{(1s)-1-Cyano-2-[4-(3-Methyl-2-Oxo-2,3-Dihydro-1,3-Benzoxazol-5-Yl)phenyl]ethyl}-1,4-Oxazepane-2-Carboxamide